Safety Study of NNZ-2566 in Healthy Female Subjects
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain evidence of the safety of NNZ-2566 in healthy female
volunteers and to determine the pharmacokinetics (PK) of NNZ-2566 in healthy female
volunteers.